Toujeo is a long-acting insulin used to treat adults with type 1 and type 2 diabetes. It is a part of the Endocrine and Metabolic Disorders Drugs market, which includes medications used to treat a variety of conditions, such as diabetes, thyroid disorders, and obesity. Toujeo is a once-daily, long-acting insulin that helps to control blood sugar levels. It is designed to provide a steady, consistent level of insulin throughout the day, helping to reduce the risk of hypoglycemia. The Endocrine and Metabolic Disorders Drugs market is a rapidly growing sector, with a wide range of products available to treat a variety of conditions. Companies in this market include Sanofi, Novo Nordisk, Eli Lilly, Merck, and AstraZeneca. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
